A comparison of incidence and risk factors for serious adverse eventsin rheumatoid arthritis patients with etanercept or adalimumab in Korea andJapan. Mod Rheumatol. 2014 Jul;24(4):572-9. http://www.ncbi.nlm.nih.gov/pubmed/24320747 後ろ向…